Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Arcellx Inc COMMON STOCK | 2,387,720 | 2,750,000 | +362,280 | $156.63M | $181.09M | 9.53% | +$24.45M |
| Jazz Pharmaceuticals plcSHS USD(JAZZ) | 0 | 1,200,000 | +1,200,000 | $0 | $127.34M | 6.70% | +$127.34M |
| Cytokinetics, Incorporated(CYTK) | 2,590,531 | 2,975,000 | +384,469 | $104.11M | $98.29M | 5.18% | -$5.82M |
| Nuvalent Inc | 1,075,000 | 1,075,000 | 0 | $76.24M | $82.02M | 4.32% | +$5.78M |
| Vera Therapeutics, Inc.CL A(VERA) | 2,500,000 | 3,100,000 | +600,000 | $60.05M | $73.04M | 3.85% | +$12.99M |
| Amicus Therapeutics Inc COM | 4,275,000 | 11,900,000 | +7,625,000 | $34.88M | $68.19M | 3.59% | +$33.30M |
| Xenon Pharmaceuticals Inc.(XENE) | 1,300,000 | 2,000,000 | +700,000 | $43.62M | $62.60M | 3.30% | +$18.98M |
| Dianthus Therapeutics, Inc.(DNTH) | 1,700,069 | 3,200,000 | +1,499,931 | $30.84M | $59.62M | 3.14% | +$28.78M |
| Scholar Rock Holding Corporation(SRRK) | 1,300,000 | 1,500,000 | +200,000 | $41.80M | $53.13M | 2.80% | +$11.34M |
| KalVista Pharmaceuticals Inc | 4,751,292 | 4,675,000 | -76,292 | $54.83M | $52.85M | 2.78% | -$1.98M |
| GE HealthCare Technologies Inc.(GEHC) | 204,130 | 700,000 | +495,870 | $16.48M | $51.85M | 2.73% | +$35.37M |
| uniQure N.V.SHS(QURE) | 4,792,572 | 3,700,000 | -1,092,572 | $50.80M | $51.58M | 2.72% | +$776.7K |
| Bicara Therapeutics Inc | 2,768,975 | 5,000,000 | +2,231,025 | $36.08M | $46.45M | 2.45% | +$10.37M |
| Alcon Inc.(ALC) | 0 | 525,000 | +525,000 | $0 | $46.35M | 2.44% | +$46.35M |
| Revolution Medicines, Inc.(RVMD) | 0 | 1,200,000 | +1,200,000 | $0 | $44.15M | 2.32% | +$44.15M |
| Crinetics Pharmaceuticals Inc | 1,500,000 | 1,500,000 | 0 | $50.31M | $43.14M | 2.27% | -$7.17M |
| Endeavour Silver Corp.(EXK) | 0 | 700,000 | +700,000 | $0 | $37.20M | 1.96% | +$37.20M |
| Celldex Therapeutics, Inc.(CLDX) | 198,646 | 1,750,000 | +1,551,354 | $3.61M | $35.61M | 1.87% | +$32.01M |
| Ascendis Pharma A/SADR(ASND) | 150,142 | 200,000 | +49,858 | $23.40M | $34.52M | 1.82% | +$11.12M |
| Immatics N.V.SHS(IMTX) | 7,192,700 | 6,250,000 | -942,700 | $32.44M | $33.63M | 1.77% | +$1.19M |
| Geron Corporation(GERN) | 22,005,340 | 23,775,000 | +1,769,660 | $34.99M | $33.52M | 1.76% | -$1.47M |
| Globus Medical, Inc.CL A(GMED) | 200,000 | 500,000 | +300,000 | $14.64M | $29.51M | 1.55% | +$14.87M |
| BioMarin Pharmaceutical Inc.(BMRN) | 0 | 500,000 | +500,000 | $0 | $27.48M | 1.45% | +$27.48M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 200,000 | 550,000 | +350,000 | $7.81M | $25.96M | 1.37% | +$18.15M |
| Tyra Biosciences, Inc.(TYRA) | 2,879,829 | 2,655,000 | -224,829 | $26.78M | $25.41M | 1.34% | -$1.37M |
| Savara Inc.(SVRA) | 11,000,000 | 11,015,000 | +15,000 | $30.47M | $25.11M | 1.32% | -$5.36M |
| The Cooper Companies, Inc.(COO) | 0 | 350,000 | +350,000 | $0 | $24.91M | 1.31% | +$24.91M |
| Structure Therapeutics IncADS | 1,788,990 | 1,200,000 | -588,990 | $30.97M | $24.89M | 1.31% | -$6.08M |
| Cidara Therapeutics Inc | 504,542 | 500,000 | -4,542 | $10.87M | $24.36M | 1.28% | +$13.49M |
| Astria Therapeutics Inc | 4,180,000 | 4,522,000 | +342,000 | $22.32M | $24.24M | 1.28% | +$1.92M |
| Abbott Laboratories | 0 | 175,000 | +175,000 | $0 | $23.80M | 1.25% | +$23.80M |
| Edwards Lifesciences Corp | 0 | 300,000 | +300,000 | $0 | $23.46M | 1.24% | +$23.46M |
| Nurix Therapeutics, Inc.(NRIX) | 1,125,552 | 2,000,000 | +874,448 | $13.37M | $22.78M | 1.20% | +$9.41M |
| Cogent Biosciences, Inc.(COGT) | 3,000,000 | 3,080,000 | +80,000 | $17.97M | $22.11M | 1.16% | +$4.14M |
| Bruker Corporation(BRKR) | 300,000 | 500,000 | +200,000 | $12.52M | $20.60M | 1.08% | +$8.08M |
| Ionis Pharmaceuticals, Inc.(IONS) | 0 | 500,000 | +500,000 | $0 | $19.75M | 1.04% | +$19.75M |
| Day One Biopharmaceuticals Inc COM | 2,598,127 | 3,000,000 | +401,873 | $20.60M | $19.50M | 1.03% | -$1.10M |
| Medtronic plcSHS(MDT) | 0 | 195,000 | +195,000 | $0 | $17.00M | 0.89% | +$17.00M |
| Perrigo Company plcSHS(PRGO) | 587,649 | 625,000 | +37,351 | $16.48M | $16.70M | 0.88% | +$222.3K |
| Zymeworks Inc.(ZYME) | 500,000 | 1,150,000 | +650,000 | $5.96M | $14.43M | 0.76% | +$8.48M |
| Black Diamond Therapeutics Inc | 5,600,000 | 5,600,000 | 0 | $8.68M | $13.89M | 0.73% | +$5.21M |
| Lexeo Therapeutics, Inc.(LXEO) | 1,136,249 | 3,228,161 | +2,091,912 | $3.94M | $12.98M | 0.68% | +$9.03M |
| Nyxoah SASHS SHS | 2,318,954 | 1,402,002 | -916,952 | $16.19M | $10.49M | 0.55% | -$5.70M |
| Thermo Fisher Scientific Inc.(TMO) | 0 | 25,000 | +25,000 | $0 | $10.14M | 0.53% | +$10.14M |
| Danaher Corporation(DHR) | 125,000 | 50,000 | -75,000 | $25.63M | $9.88M | 0.52% | -$15.75M |
| Beta Bionics, Inc.(BBNX) | 0 | 550,000 | +550,000 | $0 | $8.01M | 0.42% | +$8.01M |
| Disc Medicine, Inc.(IRON) | 0 | 140,000 | +140,000 | $0 | $7.41M | 0.39% | +$7.41M |
| Solid Biosciences Inc | 1,753,558 | 1,505,000 | -248,558 | $6.49M | $7.33M | 0.39% | +$841.2K |
| Taysha Gene Therapies, Inc.(TSHA) | 0 | 3,000,000 | +3,000,000 | $0 | $6.93M | 0.36% | +$6.93M |
| Dyne Therapeutics, Inc.(DYN) | 1,800,000 | 727,500 | -1,072,500 | $18.83M | $6.93M | 0.36% | -$11.90M |
| Travere Therapeutics, Inc.(TVTX) | 0 | 355,000 | +355,000 | $0 | $5.25M | 0.28% | +$5.25M |
| Enliven Therapeutics Inc | 0 | 250,000 | +250,000 | $0 | $5.01M | 0.26% | +$5.01M |
| Voyager Therapeutics, Inc.(VYGR) | 1,249,418 | 1,475,000 | +225,582 | $4.22M | $4.59M | 0.24% | +$364.2K |
| Zimmer Biomet Holdings, Inc.(ZBH) | 0 | 50,000 | +50,000 | $0 | $4.56M | 0.24% | +$4.56M |
| Becton, Dickinson and Company(BDX) | 0 | 25,000 | +25,000 | $0 | $4.31M | 0.23% | +$4.31M |
| Ventyx Biosciences Inc | 2,000,000 | 2,000,000 | 0 | $2.30M | $4.28M | 0.23% | +$1.98M |
| Lantheus Holdings, Inc.(LNTH) | 0 | 50,000 | +50,000 | $0 | $4.09M | 0.22% | +$4.09M |
| Neurocrine Biosciences, Inc.(NBIX) | 0 | 30,000 | +30,000 | $0 | $3.77M | 0.20% | +$3.77M |
| Applied Therapeutics Inc | 11,500,000 | 11,500,000 | 0 | $5.62M | $3.58M | 0.19% | -$2.04M |
| Fate Therapeutics, Inc.(FATE) | 2,515,850 | 2,515,000 | -850 | $1.99M | $2.82M | 0.15% | +$829.0K |
| Passage Bio, Inc.(PASG) | 6,100,000 | 6,100,000 | 0 | $2.15M | $2.44M | 0.13% | +$287.9K |
| Alto Neuroscience, Inc.(ANRO) | 915,000 | 950,000 | +35,000 | $1.98M | $2.09M | 0.11% | +$113.6K |
| Sutro Biopharma, Inc.(STRO) | 2,600,000 | 2,600,000 | 0 | $1.69M | $1.86M | 0.10% | +$164.6K |
| OnKure Therapeutics, Inc.CL A(OKUR) | 635,000 | 635,000 | 0 | $2.73M | $1.52M | 0.08% | -$1.21M |
| Viridian Therapeutics, Inc.(VRDN) | 0 | 100,000 | +100,000 | $0 | $1.40M | 0.07% | +$1.40M |
| Alector Inc | 504,540 | 976,992 | +472,452 | $620.6K | $1.37M | 0.07% | +$747.2K |
| Engene Holdings Inc COM | 370,000 | 370,000 | 0 | $1.66M | $1.35M | 0.07% | -$310.8K |
| Arcutis Biotherapeutics, Inc.(ARQT) | 0 | 95,000 | +95,000 | $0 | $1.33M | 0.07% | +$1.33M |
| Atara Biotherapeutics Inc | 94,085 | 94,085 | 0 | $558.9K | $726.3K | 0.04% | +$167.5K |
| MacroGenics, Inc.(MGNX) | 280,000 | 280,000 | 0 | $355.6K | $338.8K | 0.02% | -$16.8K |
| Tenax Therapeutics, Inc.(TENX) | 53,439 | 53,439 | 0 | $350.0K | $307.8K | 0.02% | -$42.2K |
| Traws Pharma, Inc.(TRAW) | 175,000 | 149,800 | -25,200 | $402.5K | $221.7K | 0.01% | -$180.8K |
| Arcturus Therapeutics Holdings Inc.(ARCT) | 211,790 | 0 | -211,790 | $2.24M | $0 | — | -$2.24M |
| Centessa Pharmaceuticals PLCADS | 14,888 | 0 | -14,888 | $214.1K | $0 | — | -$214.1K |
| Establishment Labs Holdings Inc.(ESTA) | 433,193 | 0 | -433,193 | $17.68M | $0 | — | -$17.68M |
| Lakefront Biotherapeutics NVADR(LKFT) | 200,000 | 0 | -200,000 | $5.02M | $0 | — | -$5.02M |
| Immunovant, Inc.(IMVT) | 350,000 | 0 | -350,000 | $5.98M | $0 | — | -$5.98M |
| Insmed Incorporated(INSM) | 1,075,000 | 0 | -1,075,000 | $82.01M | $0 | — | -$82.01M |
| iTeos Therapeutics Inc | 900,000 | 0 | -900,000 | $5.37M | $0 | — | -$5.37M |
| Kiniksa Pharmaceuticals International, plcCL A(KNSA) | 169,864 | 0 | -169,864 | $3.77M | $0 | — | -$3.77M |
| Liquidia Corporation(LQDA) | 1,227,403 | 0 | -1,227,403 | $18.10M | $0 | — | -$18.10M |
| Sarepta Therapeutics, Inc.(SRPT) | 200,000 | 0 | -200,000 | $12.76M | $0 | — | -$12.76M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 500,000 | 0 | -500,000 | $18.11M | $0 | — | -$18.11M |
| UroGen Pharma Ltd.(URGN) | 2,152,957 | 0 | -2,152,957 | $23.81M | $0 | — | -$23.81M |
| Verona Pharma PLCADS | 267,627 | 0 | -267,627 | $16.99M | $0 | — | -$16.99M |